nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—CYP2C8—Tamoxifen—pancreatic cancer	0.0833	0.182	CbGbCtD
Eszopiclone—CYP2C8—Erlotinib—pancreatic cancer	0.0708	0.155	CbGbCtD
Eszopiclone—CYP2C8—Fluorouracil—pancreatic cancer	0.0614	0.134	CbGbCtD
Eszopiclone—CYP2C9—Tamoxifen—pancreatic cancer	0.0581	0.127	CbGbCtD
Eszopiclone—CYP2C9—Fluorouracil—pancreatic cancer	0.0428	0.0937	CbGbCtD
Eszopiclone—CYP3A4—Tamoxifen—pancreatic cancer	0.0338	0.0739	CbGbCtD
Eszopiclone—CYP3A4—Erlotinib—pancreatic cancer	0.0287	0.0628	CbGbCtD
Eszopiclone—CYP3A4—Irinotecan—pancreatic cancer	0.0259	0.0568	CbGbCtD
Eszopiclone—CYP3A4—Docetaxel—pancreatic cancer	0.019	0.0416	CbGbCtD
Eszopiclone—CYP3A4—Sunitinib—pancreatic cancer	0.0189	0.0414	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—pancreatic cancer	0.0142	0.031	CbGbCtD
Eszopiclone—Pain—Gemcitabine—pancreatic cancer	0.000415	0.000764	CcSEcCtD
Eszopiclone—Constipation—Gemcitabine—pancreatic cancer	0.000415	0.000764	CcSEcCtD
Eszopiclone—Nausea—Erlotinib—pancreatic cancer	0.000415	0.000764	CcSEcCtD
Eszopiclone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000415	0.000764	CcSEcCtD
Eszopiclone—Mood swings—Doxorubicin—pancreatic cancer	0.000414	0.000763	CcSEcCtD
Eszopiclone—Diarrhoea—Sunitinib—pancreatic cancer	0.000414	0.000762	CcSEcCtD
Eszopiclone—Dysgeusia—Docetaxel—pancreatic cancer	0.000413	0.000761	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000412	0.000759	CcSEcCtD
Eszopiclone—Ataxia—Doxorubicin—pancreatic cancer	0.000411	0.000757	CcSEcCtD
Eszopiclone—Feeling abnormal—Irinotecan—pancreatic cancer	0.00041	0.000756	CcSEcCtD
Eszopiclone—Asthma—Epirubicin—pancreatic cancer	0.000408	0.000752	CcSEcCtD
Eszopiclone—Influenza—Epirubicin—pancreatic cancer	0.000408	0.000752	CcSEcCtD
Eszopiclone—Dysphagia—Epirubicin—pancreatic cancer	0.000408	0.000752	CcSEcCtD
Eszopiclone—Back pain—Docetaxel—pancreatic cancer	0.000408	0.000752	CcSEcCtD
Eszopiclone—Pain—Fluorouracil—pancreatic cancer	0.000408	0.000751	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000407	0.00075	CcSEcCtD
Eszopiclone—Dehydration—Doxorubicin—pancreatic cancer	0.000407	0.000749	CcSEcCtD
Eszopiclone—Muscle spasms—Docetaxel—pancreatic cancer	0.000406	0.000747	CcSEcCtD
Eszopiclone—Dry skin—Doxorubicin—pancreatic cancer	0.000401	0.000738	CcSEcCtD
Eszopiclone—Dizziness—Sunitinib—pancreatic cancer	0.0004	0.000736	CcSEcCtD
Eszopiclone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.0004	0.000736	CcSEcCtD
Eszopiclone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000398	0.000733	CcSEcCtD
Eszopiclone—Body temperature increased—Irinotecan—pancreatic cancer	0.000394	0.000725	CcSEcCtD
Eszopiclone—Abdominal pain—Irinotecan—pancreatic cancer	0.000394	0.000725	CcSEcCtD
Eszopiclone—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000394	0.000725	CcSEcCtD
Eszopiclone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000393	0.000724	CcSEcCtD
Eszopiclone—Bronchitis—Epirubicin—pancreatic cancer	0.000393	0.000723	CcSEcCtD
Eszopiclone—Anaemia—Docetaxel—pancreatic cancer	0.00039	0.000718	CcSEcCtD
Eszopiclone—Gastritis—Doxorubicin—pancreatic cancer	0.000387	0.000713	CcSEcCtD
Eszopiclone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000386	0.00071	CcSEcCtD
Eszopiclone—Vomiting—Sunitinib—pancreatic cancer	0.000384	0.000708	CcSEcCtD
Eszopiclone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000384	0.000706	CcSEcCtD
Eszopiclone—Dysuria—Epirubicin—pancreatic cancer	0.000382	0.000703	CcSEcCtD
Eszopiclone—Rash—Sunitinib—pancreatic cancer	0.000381	0.000702	CcSEcCtD
Eszopiclone—Dermatitis—Sunitinib—pancreatic cancer	0.000381	0.000702	CcSEcCtD
Eszopiclone—Urticaria—Fluorouracil—pancreatic cancer	0.000379	0.000698	CcSEcCtD
Eszopiclone—Headache—Sunitinib—pancreatic cancer	0.000379	0.000698	CcSEcCtD
Eszopiclone—Asthma—Doxorubicin—pancreatic cancer	0.000378	0.000696	CcSEcCtD
Eszopiclone—Dysphagia—Doxorubicin—pancreatic cancer	0.000378	0.000696	CcSEcCtD
Eszopiclone—Influenza—Doxorubicin—pancreatic cancer	0.000378	0.000696	CcSEcCtD
Eszopiclone—Pollakiuria—Epirubicin—pancreatic cancer	0.000377	0.000695	CcSEcCtD
Eszopiclone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000377	0.000695	CcSEcCtD
Eszopiclone—Palpitations—Docetaxel—pancreatic cancer	0.000373	0.000687	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000373	0.000687	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—pancreatic cancer	0.000372	0.000685	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—pancreatic cancer	0.000369	0.00068	CcSEcCtD
Eszopiclone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000367	0.000676	CcSEcCtD
Eszopiclone—Convulsion—Docetaxel—pancreatic cancer	0.000366	0.000673	CcSEcCtD
Eszopiclone—Hypertension—Docetaxel—pancreatic cancer	0.000364	0.000671	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—pancreatic cancer	0.000364	0.000671	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—pancreatic cancer	0.000363	0.000669	CcSEcCtD
Eszopiclone—Myalgia—Docetaxel—pancreatic cancer	0.000359	0.000662	CcSEcCtD
Eszopiclone—Chest pain—Docetaxel—pancreatic cancer	0.000359	0.000662	CcSEcCtD
Eszopiclone—Nausea—Sunitinib—pancreatic cancer	0.000359	0.000661	CcSEcCtD
Eszopiclone—Asthenia—Irinotecan—pancreatic cancer	0.000357	0.000658	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000357	0.000657	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—pancreatic cancer	0.000355	0.000654	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—pancreatic cancer	0.000354	0.000652	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—pancreatic cancer	0.000354	0.000652	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—pancreatic cancer	0.000353	0.000651	CcSEcCtD
Eszopiclone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000351	0.000647	CcSEcCtD
Eszopiclone—Dry mouth—Docetaxel—pancreatic cancer	0.000351	0.000647	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—pancreatic cancer	0.000349	0.000643	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—pancreatic cancer	0.000349	0.000643	CcSEcCtD
Eszopiclone—Asthenia—Gemcitabine—pancreatic cancer	0.000348	0.000641	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—pancreatic cancer	0.000347	0.000639	CcSEcCtD
Eszopiclone—Confusional state—Docetaxel—pancreatic cancer	0.000347	0.000639	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000345	0.000635	CcSEcCtD
Eszopiclone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000344	0.000634	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—pancreatic cancer	0.000344	0.000633	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—pancreatic cancer	0.000343	0.000633	CcSEcCtD
Eszopiclone—Pruritus—Gemcitabine—pancreatic cancer	0.000343	0.000632	CcSEcCtD
Eszopiclone—Infection—Docetaxel—pancreatic cancer	0.000342	0.00063	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—pancreatic cancer	0.000342	0.00063	CcSEcCtD
Eszopiclone—Diarrhoea—Irinotecan—pancreatic cancer	0.000341	0.000628	CcSEcCtD
Eszopiclone—Pruritus—Fluorouracil—pancreatic cancer	0.000337	0.000622	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—pancreatic cancer	0.000337	0.000621	CcSEcCtD
Eszopiclone—Tachycardia—Docetaxel—pancreatic cancer	0.000336	0.000619	CcSEcCtD
Eszopiclone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000332	0.000611	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.00033	0.000608	CcSEcCtD
Eszopiclone—Dizziness—Irinotecan—pancreatic cancer	0.000329	0.000607	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—pancreatic cancer	0.000328	0.000605	CcSEcCtD
Eszopiclone—Anorexia—Docetaxel—pancreatic cancer	0.000328	0.000604	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—pancreatic cancer	0.000328	0.000604	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000327	0.000603	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000327	0.000603	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—pancreatic cancer	0.000327	0.000602	CcSEcCtD
Eszopiclone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000326	0.000601	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000325	0.000599	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—pancreatic cancer	0.000324	0.000598	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—pancreatic cancer	0.000323	0.000595	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—pancreatic cancer	0.000322	0.000593	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—pancreatic cancer	0.000321	0.000592	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—pancreatic cancer	0.000318	0.000585	CcSEcCtD
Eszopiclone—Vomiting—Irinotecan—pancreatic cancer	0.000317	0.000583	CcSEcCtD
Eszopiclone—Dizziness—Fluorouracil—pancreatic cancer	0.000315	0.000581	CcSEcCtD
Eszopiclone—Rash—Irinotecan—pancreatic cancer	0.000314	0.000578	CcSEcCtD
Eszopiclone—Dermatitis—Irinotecan—pancreatic cancer	0.000314	0.000578	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000314	0.000578	CcSEcCtD
Eszopiclone—Headache—Irinotecan—pancreatic cancer	0.000312	0.000575	CcSEcCtD
Eszopiclone—Insomnia—Docetaxel—pancreatic cancer	0.000311	0.000574	CcSEcCtD
Eszopiclone—Paraesthesia—Docetaxel—pancreatic cancer	0.000309	0.000569	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—pancreatic cancer	0.000309	0.000569	CcSEcCtD
Eszopiclone—Vomiting—Gemcitabine—pancreatic cancer	0.000308	0.000568	CcSEcCtD
Eszopiclone—Dyspnoea—Docetaxel—pancreatic cancer	0.000307	0.000565	CcSEcCtD
Eszopiclone—Somnolence—Docetaxel—pancreatic cancer	0.000306	0.000564	CcSEcCtD
Eszopiclone—Rash—Gemcitabine—pancreatic cancer	0.000306	0.000563	CcSEcCtD
Eszopiclone—Dermatitis—Gemcitabine—pancreatic cancer	0.000306	0.000563	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—pancreatic cancer	0.000305	0.000561	CcSEcCtD
Eszopiclone—Headache—Gemcitabine—pancreatic cancer	0.000304	0.00056	CcSEcCtD
Eszopiclone—Vomiting—Fluorouracil—pancreatic cancer	0.000303	0.000559	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—pancreatic cancer	0.000303	0.000558	CcSEcCtD
Eszopiclone—Dyspepsia—Docetaxel—pancreatic cancer	0.000303	0.000558	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—pancreatic cancer	0.000302	0.000557	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000301	0.000554	CcSEcCtD
Eszopiclone—Rash—Fluorouracil—pancreatic cancer	0.000301	0.000554	CcSEcCtD
Eszopiclone—Dermatitis—Fluorouracil—pancreatic cancer	0.0003	0.000553	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—pancreatic cancer	0.0003	0.000553	CcSEcCtD
Eszopiclone—Decreased appetite—Docetaxel—pancreatic cancer	0.000299	0.000551	CcSEcCtD
Eszopiclone—Headache—Fluorouracil—pancreatic cancer	0.000299	0.00055	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000298	0.000549	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000297	0.000547	CcSEcCtD
Eszopiclone—Fatigue—Docetaxel—pancreatic cancer	0.000297	0.000547	CcSEcCtD
Eszopiclone—Nausea—Irinotecan—pancreatic cancer	0.000296	0.000545	CcSEcCtD
Eszopiclone—Constipation—Docetaxel—pancreatic cancer	0.000294	0.000542	CcSEcCtD
Eszopiclone—Pain—Docetaxel—pancreatic cancer	0.000294	0.000542	CcSEcCtD
Eszopiclone—Chills—Epirubicin—pancreatic cancer	0.000293	0.00054	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—pancreatic cancer	0.000289	0.000532	CcSEcCtD
Eszopiclone—Nausea—Gemcitabine—pancreatic cancer	0.000288	0.000531	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000286	0.000527	CcSEcCtD
Eszopiclone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000284	0.000523	CcSEcCtD
Eszopiclone—Nausea—Fluorouracil—pancreatic cancer	0.000283	0.000522	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—pancreatic cancer	0.000282	0.000519	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000282	0.000519	CcSEcCtD
Eszopiclone—Tension—Epirubicin—pancreatic cancer	0.000279	0.000514	CcSEcCtD
Eszopiclone—Dysgeusia—Epirubicin—pancreatic cancer	0.000279	0.000513	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—pancreatic cancer	0.000276	0.000509	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—pancreatic cancer	0.000275	0.000507	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—pancreatic cancer	0.000274	0.000504	CcSEcCtD
Eszopiclone—Abdominal pain—Docetaxel—pancreatic cancer	0.000272	0.000501	CcSEcCtD
Eszopiclone—Body temperature increased—Docetaxel—pancreatic cancer	0.000272	0.000501	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—pancreatic cancer	0.000271	0.0005	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—pancreatic cancer	0.000268	0.000494	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—pancreatic cancer	0.000267	0.000492	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000264	0.000486	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—pancreatic cancer	0.000263	0.000484	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—pancreatic cancer	0.000261	0.000482	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—pancreatic cancer	0.000258	0.000476	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—pancreatic cancer	0.000258	0.000475	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—pancreatic cancer	0.000257	0.000473	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—pancreatic cancer	0.000256	0.000471	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—pancreatic cancer	0.000256	0.000471	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—pancreatic cancer	0.000255	0.000469	CcSEcCtD
Eszopiclone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000254	0.000467	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—pancreatic cancer	0.000253	0.000466	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—pancreatic cancer	0.000251	0.000463	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—pancreatic cancer	0.000248	0.000457	CcSEcCtD
Eszopiclone—Asthenia—Docetaxel—pancreatic cancer	0.000247	0.000455	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—pancreatic cancer	0.000247	0.000454	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—pancreatic cancer	0.000246	0.000452	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000244	0.00045	CcSEcCtD
Eszopiclone—Pruritus—Docetaxel—pancreatic cancer	0.000244	0.000449	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—pancreatic cancer	0.000243	0.000448	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—pancreatic cancer	0.000242	0.000446	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—pancreatic cancer	0.000242	0.000446	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—pancreatic cancer	0.000242	0.000446	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—pancreatic cancer	0.000241	0.000445	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—pancreatic cancer	0.000239	0.000441	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—pancreatic cancer	0.000237	0.000437	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—pancreatic cancer	0.000237	0.000436	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—pancreatic cancer	0.000237	0.000436	CcSEcCtD
Eszopiclone—Diarrhoea—Docetaxel—pancreatic cancer	0.000236	0.000434	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—pancreatic cancer	0.000234	0.000431	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—pancreatic cancer	0.000233	0.000429	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000232	0.000428	CcSEcCtD
Eszopiclone—Infection—Epirubicin—pancreatic cancer	0.000231	0.000425	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—pancreatic cancer	0.000228	0.00042	CcSEcCtD
Eszopiclone—Dizziness—Docetaxel—pancreatic cancer	0.000228	0.000419	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—pancreatic cancer	0.000227	0.000419	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—pancreatic cancer	0.000227	0.000417	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000224	0.000413	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—pancreatic cancer	0.000224	0.000413	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—pancreatic cancer	0.000224	0.000413	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—pancreatic cancer	0.000223	0.000411	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—pancreatic cancer	0.000221	0.000408	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—pancreatic cancer	0.000221	0.000408	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—pancreatic cancer	0.000219	0.000404	CcSEcCtD
Eszopiclone—Vomiting—Docetaxel—pancreatic cancer	0.000219	0.000403	CcSEcCtD
Eszopiclone—Rash—Docetaxel—pancreatic cancer	0.000217	0.0004	CcSEcCtD
Eszopiclone—Dermatitis—Docetaxel—pancreatic cancer	0.000217	0.000399	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—pancreatic cancer	0.000217	0.000399	CcSEcCtD
Eszopiclone—Headache—Docetaxel—pancreatic cancer	0.000216	0.000397	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000215	0.000396	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—pancreatic cancer	0.000213	0.000393	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000212	0.00039	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—pancreatic cancer	0.00021	0.000387	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—pancreatic cancer	0.00021	0.000386	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—pancreatic cancer	0.000209	0.000384	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000208	0.000383	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—pancreatic cancer	0.000207	0.000381	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—pancreatic cancer	0.000206	0.00038	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—pancreatic cancer	0.000205	0.000377	CcSEcCtD
Eszopiclone—Nausea—Docetaxel—pancreatic cancer	0.000205	0.000377	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—pancreatic cancer	0.000204	0.000377	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—pancreatic cancer	0.000202	0.000372	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.0002	0.000369	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—pancreatic cancer	0.0002	0.000369	CcSEcCtD
Eszopiclone—Pain—Epirubicin—pancreatic cancer	0.000199	0.000366	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—pancreatic cancer	0.000199	0.000366	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000196	0.000361	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—pancreatic cancer	0.000194	0.000358	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—pancreatic cancer	0.000193	0.000355	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—pancreatic cancer	0.000192	0.000353	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000191	0.000352	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—pancreatic cancer	0.000191	0.000352	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00019	0.00035	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000189	0.000348	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000187	0.000344	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000186	0.000342	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—pancreatic cancer	0.000185	0.000341	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—pancreatic cancer	0.000184	0.00034	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—pancreatic cancer	0.000184	0.000338	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—pancreatic cancer	0.000184	0.000338	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—pancreatic cancer	0.000184	0.000338	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—pancreatic cancer	0.000184	0.000338	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000177	0.000326	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000176	0.000324	CcSEcCtD
Eszopiclone—Hypersensitivity—Epirubicin—pancreatic cancer	0.000171	0.000315	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—pancreatic cancer	0.000171	0.000314	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—pancreatic cancer	0.00017	0.000313	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—pancreatic cancer	0.00017	0.000313	CcSEcCtD
Eszopiclone—Asthenia—Epirubicin—pancreatic cancer	0.000167	0.000307	CcSEcCtD
Eszopiclone—Pruritus—Epirubicin—pancreatic cancer	0.000164	0.000303	CcSEcCtD
Eszopiclone—Diarrhoea—Epirubicin—pancreatic cancer	0.000159	0.000293	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000158	0.000292	CcSEcCtD
Eszopiclone—Asthenia—Doxorubicin—pancreatic cancer	0.000154	0.000284	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—pancreatic cancer	0.000154	0.000283	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—pancreatic cancer	0.000152	0.00028	CcSEcCtD
Eszopiclone—Vomiting—Epirubicin—pancreatic cancer	0.000148	0.000272	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—pancreatic cancer	0.000147	0.000271	CcSEcCtD
Eszopiclone—Rash—Epirubicin—pancreatic cancer	0.000146	0.00027	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—pancreatic cancer	0.000146	0.000269	CcSEcCtD
Eszopiclone—Headache—Epirubicin—pancreatic cancer	0.000145	0.000268	CcSEcCtD
Eszopiclone—Dizziness—Doxorubicin—pancreatic cancer	0.000142	0.000262	CcSEcCtD
Eszopiclone—Nausea—Epirubicin—pancreatic cancer	0.000138	0.000254	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—pancreatic cancer	0.000137	0.000252	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—pancreatic cancer	0.000135	0.00025	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—pancreatic cancer	0.000135	0.000249	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—pancreatic cancer	0.000135	0.000248	CcSEcCtD
Eszopiclone—Nausea—Doxorubicin—pancreatic cancer	0.000128	0.000235	CcSEcCtD
